But can the pocket afford it? 🤔
to fight Type 2 diabetes. A Phase 3 clinical trial of the same drug to test its effect on weight loss in obese and overweight people has shown some promising results., obesity is a serious disease in the U.S. affecting as many as 42 percent of the population. It also increases the risk of other illnesses such as cardiovascular conditions, type 2 diabetes, and some types of cancer.
While some take the slow way of eating a balanced diet and an increase in physical activity to bring their weight under control, others opt for surgical interventions to see a substantial loss in weight. A once-a-week skin injection could alsoDeveloped by U.S. pharmaceutical company Eli Lilly, the drug Tirzepatide combines two synthetic incretins, GLP-1 and GIP. Incretins are naturally occurring hormones in the body involved in food digestion and help lower blood sugar after we consume a meal.
In 2021, the FDA also approved a GLP-1-based drug, semaglutide, as a weight-loss drug after encouraging results in clinical trials. Since Eli Lilly's tirzepatide uses GLP-1, researchers wanted to know if it could be used as a weight-loss medication too.The researchers enrolled 2,539 participants who were either overweight or obese for the study to investigate.
The drug was administered as a weekly injection. Individuals receiving the drug were categorized into three dose groups; 5 mg, 10 mg, and 15 mg. Preliminary results of the trial that is still ongoing came out in April this year and have now undergone peer review and have been published in theAccording to the researchers, all three groups of patients who received the drug showed significant weight loss. On average, patients who received the 15 mg dose showed a 22.
. So, even if science were to bring a cure for obesity, economics would block it from being accessible to those who need it. Stay ahead with the latest science, technology and innovation news, for free:
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
'Smart Inhalers' May Help Diagnose and Treat Asthma – If UsedAfter years going on and off medications for asthma symptoms, things went downhill for Brian Blome in November 2020. The retired carpenter was feeling short of breath and wheezing during bike rides.
Baca lebih lajut »
Bedbugs' biggest impact may be on mental health after an infestation of these bloodsucking parasitesBedbugs are pretty much universally reviled. But a public health entomologist explains how, while potentially traumatizing to deal with, they aren’t likely to make you sick.
Baca lebih lajut »
4 Subtle Signs You May Have Had a Seizure Without Knowing — Best LifeSo-called 'absence seizures' are difficult to detect. Here are four subtle symptoms that may mean you've had a seizure without realizing it.
Baca lebih lajut »
AAA: This year's '100 deadliest days' may not just be a danger for teen driversEach year, AAA warns of the '100 deadliest days' for teen drivers, but this year the company warns data has shown the first days of the summer months could be just as dangerous for all drivers.
Baca lebih lajut »
Tell Us About Your Pop Culture Month: May 2022 EditionIt's June, you basically know how this goes by now.
Baca lebih lajut »